Vitrafy enters a partnership with Hoxworth Blood Center
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Vitrafy Life Sciences Ltd announces a partnership with Hoxworth Blood Center to enhance its cryopreservation ecosystem for red blood cells, addressing a critical industry challenge. This collaboration aims to respond to the impending discontinuation of legacy cryopreservation technology, which poses risks to blood preservation capabilities. Vitrafy plans to install a cryopreservation unit at Hoxworth and seeks to engage with various stakeholders for a unified industry response.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Vitrafy Life Sciences Ltd. on 6ix
Earlier from Vitrafy Life Sciences
- Vitrafy Share Purchase Plan Opens - SPP Offer Booklet
- Vitrafy Placement Completion and SPP Announcement
- Vitrafy Equity Raising Presentation
- Trading Halt
- Vitrafy enters a partnership with Vitalant Innovation Center
Later from Vitrafy Life Sciences
- Q4 FY26 Quarterly Activities Report and Appendix 4C
- Vitrafy FY26 Investor Briefing
- FY26 Appendix 4G
- FY26 Corporate Governance Statement
- FY26 Appendix 4E and Annual Report
Follow Vitrafy Life Sciences into a list and get an email when it puts out news.
Follow Vitrafy Life Sciences